Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2007
12/20/2007US20070292915 Human OCT-2 Variant Peptide Chains, Nucleic Acids, and Methods
12/20/2007US20070292914 Nucleic acid sequence encoding a polypeptide having acetohydroxy acid synthetase (AHAS) activity; fermentative production of branched-chain amino acids using these enzymes in specific hosts in which genes which code for the modified AHAS are expressed
12/20/2007US20070292913 Novel Bacterial Expression System
12/20/2007US20070292909 Fluorescent Protein
12/20/2007US20070292898 Functional Screening Assay
12/20/2007US20070292885 Human cdnas and proteins and uses thereof
12/20/2007US20070292859 Association of Protein Polymorphisms With Coronary Heart Disease
12/20/2007US20070292847 nucleic acid molecule encoding a protein that hydrolyzes cyclic adenosine mono-phosphate (cAMP); leishmaniasis
12/20/2007US20070292840 Replication Competent Hepatitis C Virus and Methods of Use
12/20/2007US20070292520 Pulmonary Insulin Crystals
12/20/2007US20070292490 Production of tissue factor in plants
12/20/2007US20070292450 Immunogenic Compositions of Staphylococcus Epidermidis Polypeptide Antigens
12/20/2007US20070292449 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
12/20/2007US20070292443 Polypeptides with multifunction
12/20/2007US20070292441 Tumor Specific Antibody
12/20/2007US20070292437 Chlamydia PMP Proteins, Gene Sequences and Uses Thereof
12/20/2007US20070292436 Immunogenic proteoliposomes, and uses thereof
12/20/2007US20070292435 Polypeptide for use in the treatment of tumors, autoimmune, inflammatory and viral diseases; graft vs. host disease
12/20/2007US20070292427 Substantially pure steroidogenesis inducing peptide and uses thereof
12/20/2007US20070292426 Methods and compositions based on Shiga toxin type 1 protein
12/20/2007US20070292425 Chlamydia PMP Proteins, Gene Sequences and Uses Thereof
12/20/2007US20070292424 Novel human eosinophil-derived basic protein
12/20/2007US20070292415 Compositions and methods for the therapy and diagnosis of breast cancer
12/20/2007US20070292410 Using mutant superoxide dismutase 1 (SOD1) as tool in diagnosis, prevention and treatment of nervous system disorders
12/20/2007US20070292393 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma
12/20/2007US20070292387 Transmucosal delivery of pharmaceutical active substances
12/20/2007US20070292347 Peptides Associated with Hla-Dr Mhc Clas II Molecules Involved in Autoimmune Diseases
12/20/2007US20070290173 Highly homogenoeous molecular markers for electrophoresis
12/20/2007US20070289708 Method for attaching two surfaces to each other using a bioadhesive polyphenolic protein and periodate ions
12/20/2007CA2635467A1 Bst2 inhibitor
12/20/2007CA2592372A1 Angiopoietin-like 2 as a biomarker of vascular endothelial cell abnormal function and senescence
12/19/2007EP1867721A1 Angiostatin fragments and aggregate angiostatin and methods of use
12/19/2007EP1867720A2 Purified genes encoding mammalian cell surface antigens; proteins and antibodies
12/19/2007EP1867719A2 Methods and compositions for inhibiting neoplastic cell growth
12/19/2007EP1867717A1 Method of ameliorating symptom caused by mood disturbance
12/19/2007EP1867658A1 Lactalbumin production process
12/19/2007EP1867657A1 Process for the preparation of poly-a-glutamic acid and derivatives thereof
12/19/2007EP1866427A2 Manufacturing process for the production of peptides grown in insect cell lines
12/19/2007EP1866421A2 Methods and composition related to in vivo imaging of gene expression
12/19/2007EP1866415A2 A cysteine-containing peptide tag for site-specific conjugation of proteins
12/19/2007EP1866338A1 Antibodies against cd38 for treatment of multiple myeloma
12/19/2007EP1866335A2 MEANS FOR THE INHIBITION OF ANTI- ß1-ADRENERGIC RECEPTOR ANTIBODIES
12/19/2007EP1866334A1 Inhibitor of endogenous human interferon - gamma
12/19/2007EP1866333A1 Human cancer suppressor gene, protein encoded therein
12/19/2007EP1866332A1 Use of crotamine, kit and composition
12/19/2007EP1866331A2 Methods and means for determining and conferring stress tolerance in plants
12/19/2007EP1866330A2 Method and device for detecting feline immunodeficiency virus
12/19/2007EP1866329A1 Peptides for inhibiting transglutaminase
12/19/2007EP1865979A2 Treatment of cognitive and learning impairment
12/19/2007EP1865773A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
12/19/2007EP1723171B1 Method for the purification of an n-terminal fragment of hepatocyte growth factor
12/19/2007EP1558278A4 Production of homotrimeric fusion proteins
12/19/2007EP1311540B1 Altered ospa of borrelia burgdorferi
12/19/2007EP1305435B1 Use of herpes simplex virus glycoprotein d to suppress immune responses
12/19/2007EP1287014B1 Enhanced protein thermostability and temperature resistance
12/19/2007EP1282822B1 Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen
12/19/2007EP1230369B1 Polypeptide hormone phosphatonin
12/19/2007EP1194033B1 Transgenically produced antithrombin iii and mutants thereof
12/19/2007EP1179593B1 Process for producing recombinant insulin from novel fused protein
12/19/2007EP1095061B1 Peptides based on the sequence of human lactoferrin and their use
12/19/2007EP1090033B2 Particles of hcv envelope proteins: use for vaccination
12/19/2007EP0954578B1 Glycoprotein hormone (tsh) superagonists
12/19/2007EP0934337B1 A process for purifying apolipoprotein a or apolipoprotein e from human plasma
12/19/2007EP0772689B1 Retroviral vectors having a reduced recombination rate
12/19/2007EP0594669B2 Growth factor-responsive neural progenitor cells which can be proliferated in vitro.
12/19/2007EP0570422B1 Stamen-specific promoters from corn
12/19/2007EP0519001B2 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
12/19/2007CN101090980A 经修饰的人类生长激素 Modified human growth hormone
12/19/2007CN101090973A Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby
12/19/2007CN101090967A Site specific system for generating diversity protein sequences
12/19/2007CN101090912A Torc polynucleotides and polypeptides, and methods of use
12/19/2007CN101090911A L-glutamic acid-producing microorganism and a method for producing l-glutamic acid
12/19/2007CN101090729A Antibodies and related molecules that bind to psca proteins
12/19/2007CN101089186A Expression carrier for human L-type complement agglutinant fibre gelled protein and construction and application
12/19/2007CN101089184A Whole gene group sequence of high temp double-chain DNA bacteriophase GBSV1
12/19/2007CN101089183A Sequence regulating the anther-specific expression of a gene and its use in the production of androsterile plants and hybrid seeds
12/19/2007CN101089182A Leaf senile correlation gene and its code protein and application
12/19/2007CN101089181A Production method of recombination human interleukin-4
12/19/2007CN101089180A Recombination LFA3 gene, and its mixed gene and product
12/19/2007CN101089179A Hog B-lymphocyte irritation factor CDNA and its clone method and recombination application
12/19/2007CN101089020A VIP analog and its radioactive marker and their prepn process
12/19/2007CN101089019A Polypeptides with antithrombotic activity and their prepn process and application
12/19/2007CN101089018A Woodfrog egg protein with anticancer function and its prepn process
12/19/2007CN101089017A Process of separating and purifying melittin
12/19/2007CN101089016A Dactinomycin refining process
12/19/2007CN101088561A Anti hepatitis c virus antibody and uses thereof
12/19/2007CN100355881C Plant expression carrier plasmid for hepatitis B gene, hepatitis B gene transgenic cell line and its industrialization production application
12/19/2007CN100355788C Activated collagen protein stent material and its special restoration factor for binding
12/19/2007CN100355787C Activated collagen bone restoration material and its special bone restoration factor for bone binding
12/19/2007CN100355786C Polyethylene glycol-modified thymus peptide 1 derivatives
12/19/2007CN100355784C Method for preparing polyethylene glycol-modified alpha-interferon 1b
12/19/2007CN100355783C Anti-coagulate protein and its coding gene and high effective expression method
12/19/2007CN100355782C New liver cancer up expressing gene and its encoded protein and application
12/19/2007CN100355781C 肽 Peptide
12/19/2007CN100355780C Wheat seed hardness relative protein and its code gene and application
12/19/2007CN100355779C Wheat seed hardness relative protein and its code gene and application
12/19/2007CN100355778C 玉米根优先启动子及其用途 Corn root priority promoters and their uses
12/19/2007CN100355777C Hepatitis B virus pre-S mutain, and its preparing process and application
12/19/2007CN100355774C Recombinant human interferon alpha-2b(rhIFN alpha-2b) stock preparing method
12/19/2007CN100355453C Improved vaccines